-
Visine A.C. Seasonal Itching and Redness Relief Drops (Pfizer Consumer)
Description: Visine A.C. is a sterile, isotonic, buffered ophthalmic solution containing tetrahydrozoline hydrochloride and zinc sulfate. Visine A.C. is a fast-acting, dual-action ophthalmic solution combining the redness reliever, tetrahydrozoline hydrochloride, with the astringent, zinc sulfate. The redness reliever provides temporary relief of conjunctival hyperemia while the astringent helps to relieve itching, burning, watery eyes due to pollen, dust and ragweed.
Active ingredients Purpose
Tetrahydrozoline HCl 0.05% Redness reliever
Zinc sulfate 0.25% ............................... Astringent
Use
- for temporary relief of discomfort and redness of the eye due to minor eye irritations
Warnings
Ask a doctor before use if you have narrow angle glaucoma
When using this product
- pupils may become enlarged temporarily
- overuse may cause more eye redness
- remove contact lenses before using
- do not use if this solution changes color or becomes cloudy
- do not touch tip of container to any surface to avoid contamination
- replace cap after each use
Stop use and ask a doctor if
- you feel eye pain
- changes in vision occur
- redness or irritation of the eye lasts
- condition worsens or lasts more than 72 hours
If pregnant or breast feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- put 1 to 2 drops in the affected eye(s) up to 4 times daily
- children under 6 years of age: ask a doctor
Other Information
- some users may experience a brief tingling sensation
- store at 15° to 25°C (59° to 77°F)
Inactive Ingredients benzalkonium chloride, boric acid, edetate disodium, purified water; sodium chloride, and sodium citrate
Questions? call 1-800-223-0182, Weekdays, 9 AM - 5 PM EST
Caution: Do not use if Visine® imprinted neckband on bottle is broken or missing.
How Supplied: In ½ FL OZ and 1 FL OZ plastic dispenser bottle.
Subscribe to the "News" RSS Feed
TOP ۞